NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
school
University Rankings
subject
University Subject Rankings
insights
Subject Rankings
place
Country Rankings
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
Joshua Bauer
Vanderbilt University - Nashville / United States
Medical and Health Sciences / Biochemistry
AD Scientific Index ID: 1330566
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Joshua Bauer's MOST POPULAR ARTICLES
1-)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapiesBD Lehmann, JA Bauer, X Chen, ME Sanders, AB Chakravarthy, Y Shyr, ...The Journal of clinical investigation 121 (7), 2750-2767, 201149662011
2-)
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancerB Kumar, KG Cordell, JS Lee, FP Worden, ME Prince, HH Tran, GT Wolf, ...Journal of clinical oncology: official journal of the American Society of …, 20087032008
3-)
Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targetsJM Balko, JM Giltnane, K Wang, LJ Schwarz, CD Young, RS Cook, ...Cancer discovery 4 (2), 232-245, 20145032014
4-)
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitorsBD Lehmann, JA Bauer, JM Schafer, CS Pendleton, L Tang, KC Johnson, ...Breast Cancer Research 16, 1-14, 20143652014
5-)
Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancerL Formisano, Y Lu, A Servetto, AB Hanker, VM Jansen, JA Bauer, ...Nature communications 10 (1), 1373, 20193152019
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept